| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-11 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-10 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-10 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-10 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |